Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial

By News Health
3 weeks Ago

(MedPage Today) — SAN FRANCISCO — For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement (TMVR).
Following the…

Source link : https://www.medpagetoday.com/meetingcoverage/tct/118208

Author :

Publish date : 2025-10-29 16:42:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

‘Lean Diabetes’ a Risk Factor for Dementia?

'California Sober' Trend Gets a Little Support From Trial

Senators Trade Barbs Over Extending Enhanced Obamacare Subsidies

mRNA Flu Vaccine Tops Standard Shot in Trial

Dementia Risk Intertwined With Exercise at Two Life Stages

Medical Groups Outraged by Anthem Payment Policy Change